ALTIMMUNE, INC.

ALT · NASDAQ

Pharmaceutical Preparation Manufacturing · US

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Its diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).

Market Data

Price $3.87 -0.01 (-0.26%)

Market Cap$502M

P/E Ratio—

EPS$—

52W High$7.73

52W Low$2.90

Beta0.18

Data from Finnhub · Updated Mar 11, 2026